Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Plenaxis (abarelix) Injectable Suspension
Company:  Praecis Pharmaceuticals
Application No.:  021320
Approval Date: 11/25/2003


Date created: March 082004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.